N-Terminal Modification and Codon Reassignment with Non-Canonical Amino Acids in Proteins by Connor, Rebecca Elizabeth
N-TERMINAL MODIFICATION AND CODON REASSIGNMENT WITH 
NON-CANONICAL AMINO ACIDS IN PROTEINS 
 
 
Thesis by 
Rebecca E. Connor 
 
In Partial Fulfillment of the Requirements for the 
degree of 
Doctor of Philosophy in Chemistry 
 
 
CALIFORNIA INSTITUTE OF TECHNOLOGY 
Pasadena, California 
2008 
(Defended  February 19, 2008)
 ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 2008 
Rebecca E. Connor 
All Rights Reserved
 iii 
ACKNOWLEDGEMENTS 
  Nothing in this thesis was possible without the advice and support of my advisor 
David Tirrell. My collaborators Kostya Piatkov and Professor Alex Varshavsky were also 
vital to the work presented here. Kostya, in particular, has been invaluable and is an 
inspiration to me.  My collaborators within the Tirrell lab, Jamie Link, John Ngo, and 
Alison Glazier have also been great to work with.  
 I could not have survived Caltech without the loving support of my husband, Jason, 
and my son, Dylan. My parents have also been staunch supporters of my scientific career, 
particularly my mother, who dropped everything and stayed with me for a year to take care 
of Dylan. The friends who got me through my first year of grad school (and my first two 
trimesters) and have remained close through the years are Susanna Widicus-Weaver, 
Jeremy Weaver,  Andy Waltman and Andrew Udit.  Stacey Maskarinec has been a constant 
source of fun times, emotional support, and good advice. Jamie Link and Jay Woodward 
are like brothers to me.  John Ngo has been a sympathetic ear, an exercise partner, and a 
source for many stimulating conversations. Meg Schmitt introduced me to the wonders of 
yoga and helps me maintain my sanity in many ways.   The Askew family, Sally, Chris, 
Marielle, and Evelyn, have provided me with a happy home and surrogate family for my 
last six months in Pasadena for which I will always be grateful.  
 Everyone in the Tirrell group has been kind, helpful and knowledgeable. In 
particular, group members Shelly Tzlil, Kimberly Beatty, Marissa Mock, Mandy Vink, 
Caglar Tanrikulu, Tae Hyeon Yoo, Sarah Heilshorn, Jin Montclare, Inchan Kwon and 
Dave Flanagan have always been tremendously generous in their time and knowledge.
 iv 
ABSTRACT 
Proteins are ubiquitous macromolecules that effect and control all the processes of 
life from reproduction to respiration to physical motion. These diverse molecules also 
provide physical structure and defensive mechanisms.  The twenty canonical amino acids 
can be found in virtually every protein; however, in some organisms, the set of endogenous 
amino acids also contains residues outside the “canon,” such as pyrrolysine, selenocysteine, 
and formylmethionine. Although a range of chemistries is available through natural side-
chain diversity, some functionalities such as halogens, ketones, azides, alkenes, and alkynes 
are not found in nature. The introduction of a broader range of chemical functionality into 
proteins and protein-based materials through the use of non-canonical amino acids 
represents a challenging goal for protein engineering. The persistence of all the amino acids 
throughout protein sequences also presents a challenge for biochemical modification at a 
particular location. The insertion of a non-natural amino acid at a single location on a 
protein can allow specific modification without further affecting the natural protein 
sequence. The focus of this thesis is on a new method for the post-translational site-specific 
introduction of non-canonical amino acids to the N-terminus of proteins in vitro and 
progress made towards developing a complementary in vivo method using the E. coli L,F-
transferase. Addition of non-proteinogenic functionality to the coat proteins of M13 
bacteriophage using non-canonical amino acids is also explored. 
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